longbridge

Ernexa Therapeutics

ERNA
----

All Shareholders

Shareholder Type

  • Public and others66.84%
  • Individuals & Insiders25.40%
  • Institutions7.76%

Major Shareholders

Major Shareholders Latest
Shareholder
Charles CheringtonFormer Independent Chairman
16.61%271.18K6.64%+0
Freebird Partners LP
4.99%81.42K1.99%+0
Shameek Konar
4.31%70.34K1.72%+1.00
John HalpernFormer Director
2.85%46.45K1.14%+0
Citadel Advisors LLC
0.93%15.10K0.81%+13.78K
Vanguard Capital Management, LLC
0.86%14.02K0.68%+11.94K
David Laughlin
0.77%12.63K0.31%+0
Geode Capital Management, LLC
0.60%9.78K0.24%+0
David PolinskyDirector
0.49%8.00K--+8.00K
Dauntless Investment Group, Llc
0.37%6.00K1.73%-18.50K
Sanjeev LutherCEO, President & Director
0.31%4.98K0.09%+363.00
James BristolIndependent Chairman of the Board
0.03%417.00<0.01%+5.00
Tradewinds Capital Management, LLC
0.02%361.00--+361.00
Peter CicalaIndependent Director
0.02%256.00<0.01%-38.00
William WexlerIndependent Director
0.01%190.00<0.01%+9.00
Elena RatnerIndependent Director
0.01%166.00<0.01%+21.00
BlackRock, Inc.
<0.01%33.00<0.01%+1.00
Sandra GurrolaFormer Senior Vice President of Finance
<0.01%6.00<0.01%+2.00
AssetMark, Inc.
<0.01%5.00<0.01%+0
BNP Paribas Financial Markets SNC
<0.01%1.00<0.01%+0
© 2026 Longbridge｜Terms of ServicePrivacy Policy